⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8164385 | 1.00 | — | — | |
| SCHEMBL7400413 | 1.00 | — | — | |
| Hydrochloric Acid SCHEMBL16095751 | 0.98 | SSTR4 (0.47) | — | |
| SCHEMBL27595403 | 0.98 | SSTR4 (0.47) | — | |
| Hydrochloric Acid SCHEMBL16094440 | 0.98 | SSTR4 (0.47) | — | |
| Hydrochloric Acid SCHEMBL1609138 | 0.98 | SSTR4 (0.47) | — | |
| Trifluoroacetic Acid SCHEMBL19551067 | 0.89 | SSTR4 (0.46) | — | |
| SCHEMBL24502684 | 0.87 | SLC6A1 (0.45) | — | |
| SCHEMBL30194780 | 0.87 | SLC6A1 (0.45) | — | |
| SCHEMBL30987164 | 0.85 | SLC6A1 (0.44) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 778 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122028594-A | Solar cell, preparation method thereof, photovoltaic module, power utilization device and power generation device | 宁德时代新能源科技股份有限公司 | 2026-05-12 | — | — | CN | claimed |
| US-12024506-B2 | Compounds | THE INSTITUTE OF CANCER RESEARCH: ROYAL CANCER HOSPITAL (GB) | 2024-07-02 | — | — | US | claimed |
| US-20240174715-A1 | PEPTIDE LIBRARIES WITH NON-CANONICAL AMINO ACIDS | INDI MOLECULAR, INC. | 2024-05-30 | — | — | US | claimed |
| EP-3145943-B1 | PEPTIDES, COMPOSITIONS COMPRISING THEM AND USES IN PARTICULAR COSMETIC USES | SEDERMA SA (FR) | 2024-03-13 | — | — | EP | claimed |
| US-11919972-B2 | Peptide libraries with non-canonical amino acids | REGENERON PHARMACEUTICALS, INC. (US) | 2024-03-05 | — | — | US | claimed |
| CN-117483116-A | Morpholine heterocycle hydroxamic acid collecting agent and preparation method thereof | 天津天宝翔科技有限公司 | 2024-02-02 | — | — | CN | claimed |
| US-11814348-B2 | Oxidizing liquid media for chemical transformations | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED (US) | 2023-11-14 | — | — | US | claimed |
| CN-107001744-B | Low molecular weight graft polymers for scale inhibitors | 赫尔克里士有限公司 | 2023-06-16 | — | — | CN | claimed |
| EP-3743421-B1 | COMPOUNDS | UNIV OXFORD INNOVATION LTD (GB) | 2023-03-29 | — | — | EP | claimed |
| EP-2922864-B1 | PRO-PIGMENTING PEPTIDES | SEDERMA SA (FR) | 2023-01-04 | — | — | EP | claimed |
| EP-0621788-A4 | HEMOREGULATORY PEPTIDES. | SMITHKLINE BEECHAM CORP (US) | 1997-03-05 | — | — | EP | claimed |
| EP-0725651-A4 | HEMOREGULATORY PEPTIDES | SMITHKLINE BEECHAM CORP (US) | 1997-03-05 | — | — | EP | claimed |
| EP-0725651-A1 | HEMOREGULATORY PEPTIDES | SMITHKLINE BEECHAM CORPORATION (US) | 1996-08-14 | — | — | EP | claimed |
| EP-0701446-A1 | HEMOREGULATORY PEPTIDES | SMITHKLINE BEECHAM CORPORATION (US) | 1996-03-20 | — | — | EP | claimed |
| EP-0410320-B1 | Process for preparing lankacidine carbamate derivatives | TAKEDA CHEMICAL INDUSTRIES LTD (JP) | 1995-09-27 | — | — | EP | claimed |
| WO-1995011693-A1 | HEMOREGULATORY PEPTIDES | SMITHKLINE BEECHAM CORPORATION (US) | 1995-05-04 | — | — | WO | claimed |
| WO-1994027627-A1 | HEMOREGULATORY PEPTIDES | SMITHKLINE BEECHAM CORPORATION (US) | 1994-12-08 | — | — | WO | claimed |
| EP-0621788-A1 | HEMOREGULATORY PEPTIDES | SMITHKLINE BEECHAM CORPORATION (US) | 1994-11-02 | — | — | EP | claimed |
| CN-1077960-A | HEMOREGULATORY PEPTIDES | SMITHKLINE BEECHAM CORP (US) | 1993-11-03 | — | — | CN | claimed |
| WO-1993013789-A1 | HEMOREGULATORY PEPTIDES | SMITHKLINE BEECHAM CORPORATION (US) | 1993-07-22 | — | — | WO | claimed |